Year: 2025
Type: article
Abstract: Pharmacomicrobiomics explores the role of the gut microbiota in pharmacokinetics and pharmacodynamics, paving the way for new biomarkers and intervention strategies to reduce interindividual variability in drug response. Emerging mechanistic insights and tools enable microbiome-aware approaches as a promising new facet of personalized medicine.
DOI: 10.1002/cpt.70026
Authors: Henry J. Haiser, David de Gruijl
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4413100700